Comparison of18F SPECT with PET in myocardial imaging: A realistic thorax-cardiac phantom study

BMC Nuclear Medicine

Volumn 6, Issue , 2006, Pages

  Knešaurek, Karin ^a   Machac, Josef ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; RUBIDIUM 82; TECHNETIUM 99M;

ARTICLE; DIAGNOSTIC PROCEDURE; HEART LEFT VENTRICLE INFARCTION; HEART MUSCLE PERFUSION; IMAGING SYSTEM; INTERMETHOD COMPARISON; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 33750816810     PISSN: 14712385     EISSN: 14712385     Source Type: Journal    
DOI: 10.1186/1471-2385-6-5     Document Type: Article

References (24)

1. Matsunari I, Yoneyama T, Kanayama S, Matsudaira M, Nakajima K, Taki J, Nekolla SG, Tonami N, Hisada K: Phantom Studies for Estimation of Defect Size on Cardiac 18F SPECT and PET: Implications for Myocardial Viability Assessment. J Nucl Med 2001, 42:1579-1585.
2. Patton JA, Sandler MP, Ohana I, Weinfeld Z: High-energy (511 keV) imaging with the scintillation camera. Radiographics 1996, 16:1183-1194.
3. Sandler MP, Bax JJ, Patton JA, Visser FC, Martin WH, Wijns W: Fluorine-18-florodeoxyglucosecardiac imaging using a modified scintillation camera. J Nucl Med 1998, 39:2035-2043.
4. Matsunari I, Kanayama S, Yoneyama T, Matsudaira M, Nakajima K, Taki J, Nekolla SG, Tonami N, Hisada K: Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTC-sestamibi to assess myocardial viability and function in a single study. Eur J Nucl Med Mol Imaging 2005, 32:195-202.
5. Knešaurek K, Machac J: Improvement of the flourine-18 fluorodeoxyglucose images in simultaneous F-18 FDG/Tc-99m collimated SPECT imaging. Med Phys 1999, 26:917-923.
6. Mullani NA, Goldstein RA, Gould KL, Marani SK, Fisher DJ, O'Brien HA Jr, Loberg MD: Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 1983, 24:898-906.
7. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O'Brien HA Jr: Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med 1983, 24:907-915.
8. Goldstein RA, Mullani NA, Wong WH, Hartz RK, Hicks CH, Fuentes F, Smalling RW, Gould KL: Positron imaging of myocardial infarction with rubidium-82. J Nucl Med 1986, 27:1824-1829.
9. Yoshida K, Mullani N, Gould KL: Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996, 37:1701-1712.
10. Lin JW, Robert R, Sciacca RR, Chou R-L, Laine AF, Bergmann SR: Quantification of Myocardial Perfusion in Human Subjects Using 82Rb and Wavelet-Based Noise Reduction. J Nucl Med 2001, 42:201-208.
11. Knešaurek K, Machac J: Three-window transformation crosstalk correction for simultaneous dual-isotope imaging. J Nucl Med 1997, 38:1992-1998.
12. Bergstrom M, Eriksson L, Bohm C, Blomqvist G, Litton J: Correction for scatter radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr 1983, 10:845-850.
13. Gould KL, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW: Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med 1991, 32(1):1-9.
14. Haas F, Haehnel CJ, Picker W, Nekolla S, Martinoff S, Meisner H, Schwaiger M: Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997, 30(7):1693-1700.
15. Schoder H, Campisi R, Ohtake T, Hoh CK, Moon DH, Czernin J, Schelbert HR: Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol 1999, 33(5):1328-1337.
16. Sand NP, Bottcher M, Madsen MM, Nielsen TT, Rehling M: Evaluation of regional myocardial perfusion in patients with severe left ventricular dysfunction: comparison of 13N-ammonia PET and 99mTc sestamibi SPECT. J Nucl Cardiol 1998, 5(1):4-13.
17. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD: Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998, 98(19 Suppl):II51-56.
18. Arrighi JA, Ng CK, Dey HM, Wackers FJ, Soufer R: Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both. Am J Cardiol 1997, 80(8):1007-1013.
19. Gunning MG, Anagnostopoulos C, Knight CJ, Pepper J, Burman ED, Davies G, Fox KM, Pennell DJ, Ell PJ, Underwood SR: Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998, 98(18):1869-1874.
20. Huitink JM, Visser FC, Bax JJ, van Lingen A, Groenveld AB, Teule GJ, Visser CA: Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction. Am J Cardiol 1998, 81(9):1072-1077.
21. Levine MG, McGill CC, Ahlberg AW, White MP, Giri S, Shareef B, Waters D, Heller GV: Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999, 83(1):1-5.
22. Skoufis E, McGhie AI: Radionuclide techniques for the assessment of myocardial viability. Tex Heart Inst J 1998, 25(4):272-279.
23. Melon PG, de Landsheere CM, Degueldre C, Peters JL, Kulbertus HE, Pierard LA: Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability. J Am Coll Cardiol 1997, 30(7):1651-1659.
24. Siebelink HM, Blanksma PK, Crijns HJ, Bax JJ, van Boven AJ, Kingma T, Piers DA, Pruim J, Jager PL, Vaalburg W, van der Wall EE: No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol 2001, 37(1):81-88.